Higher expression of Caveolin-1 inhibits human small cell lung cancer (SCLC) apoptosis in vitro

Cancer Invest. 2012 Jul;30(6):453-62. doi: 10.3109/07357907.2012.675384. Epub 2012 May 1.

Abstract

Small cell lung cancer (SCLC) is the most aggressive type of lung cancer, and its treatment is closely associated with apoptosis. Caveolin-1 plays an important role in the development of a variety of human cancers. This study sought to investigate the influence of Caveolin-1 on the apoptosis of SCLC in vitro. We demonstrate that higher expression of Caveolin-1 leads to inhibition of cisplatin and Ultraviolet Radiation (UVR)-induced apoptosis in SCLC cells; and also could decrease caspase-3 activity and increase the stability of Bcl-2 at the protein level. Our findings illuminate a potential molecular mechanism regarding CAV-1's role as anti-apoptosis protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma
  • Adenocarcinoma of Lung
  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Caspase 3 / biosynthesis
  • Caveolin 1 / metabolism*
  • Cell Line, Tumor
  • Cisplatin / pharmacology
  • Down-Regulation
  • Humans
  • Lung Neoplasms / metabolism*
  • Small Cell Lung Carcinoma / metabolism*

Substances

  • Caveolin 1
  • Caspase 3
  • Cisplatin